Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0JC7A
|
|||
Former ID |
DIB013133
|
|||
Drug Name |
NP-50501
|
|||
Synonyms |
FAU; Deoxyuracil-beta-D-arabinofuranoside; FAU (2-F-Ara-deoxyuridine); 2'-fluorodeoxyuracil-beta-D-arabinofuranoside
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Preclinical | [1] | |
Company |
National Cancer Institute
|
|||
Structure |
Download2D MOL |
|||
Formula |
C9H11FN2O5
|
|||
Canonical SMILES |
C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F
|
|||
InChI |
1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)
|
|||
InChIKey |
UIYWFOZZIZEEKJ-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022659) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.